Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

SUN PHARM INDS INC

  • FDA Approval
  • Oct. 17, 2023, 11:43 UTC
  • 30
  • 0 comments

FDA approve AMPHETAMINE SULFATE

Comment Full text

NOVAST LABS

  • FDA Approval
  • Oct. 17, 2023, 11:43 UTC
  • 29
  • 0 comments

FDA approve AMPHETAMINE SULFATE

Comment Full text

CEDIPROF INC

  • FDA Approval
  • Oct. 17, 2023, 11:43 UTC
  • 34
  • 0 comments

FDA approve AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Comment Full text

ASCENT PHARMS INC

  • FDA Approval
  • Oct. 17, 2023, 11:43 UTC
  • 36
  • 0 comments

FDA approve AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Comment Full text

COMMAVE THERAP

  • FDA Approval
  • Oct. 17, 2023, 11:43 UTC
  • 34
  • 0 comments

FDA approve DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE

Comment Full text

BIONPHARMA

  • FDA Approval
  • Oct. 17, 2023, 11:43 UTC
  • 34
  • 0 comments

FDA approve AMPHETAMINE SULFATE

Comment Full text

RISE PHARMA

  • FDA Approval
  • Oct. 17, 2023, 11:43 UTC
  • 30
  • 0 comments

FDA approve AMPHETAMINE SULFATE

Comment Full text

SUN PHARM

  • FDA Approval
  • Oct. 17, 2023, 11:43 UTC
  • 34
  • 0 comments

FDA approve LORATADINE

Comment Full text

NOSTRUM LABS INC

  • FDA Approval
  • Oct. 17, 2023, 11:43 UTC
  • 29
  • 0 comments

FDA approve METHYLPHENIDATE HYDROCHLORIDE

Comment Full text

NUVO PHARM

  • FDA Approval
  • Oct. 17, 2023, 11:43 UTC
  • 31
  • 0 comments

FDA approve DEXTROAMPHETAMINE SULFATE

Comment Full text
  • Previous
  • 652
  • 653
  • 654
  • 655
  • 656
  • Next

Search

News categories

  • Technical Exchange News(11980)
  • Event(5035)
  • SEC News(247696)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(148882)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin